Option chain shows key data for Nyxoah's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Nyxoah.

Nyxoah (NASDAQ:NYXH) Stock, Option Chain

Nyxoah

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Tesla Inc. (TSLA)

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

HSAI

INDV

LILM

NYXH

TIGR

TSLA

Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday&#39;s Pre-Market Session

Penny Stocks

Small Cap

Intraday Update

ACOR

AKAN

ALPN

ANAB

APVO

CADL

CLRO

ELVN

ELYM

ENLV

ESPR

FAST

GYRE

ICCT

JANX

LOVE

MRIN

NKLA

NRIX

RCEL

RENT

RLYB

SLNA

SPRC

STEP

SUUN

VBIV

VERB

Shares of  Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

FAAS

GRFS

NBTX

U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.

CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday&#39;s Pre-Market Session

Nyxoah SA

Press Releases

Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Information on the total number of voting rights and shares

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Publication relating to transparency notifications

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy  in the Middle East

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Nyxoah Reports Fourth Quarter and Financial Year  2024 Financial and Operating Results

Comments

Nyxoah

Nyxoah (NYXH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga